Clinical Device Trials

As part of its mission to innovate ophthalmic care delivery in nontraditional settings, the CORAP team is actively evaluating remote diagnostic devices from multiple vendors. By trialing different models in real-world outreach environments, such as mobile clinics and community sites, we aim to identify the equipment and workflows that function best across varied settings to inform remote care delivery in Primary Care offices, Emergency Departments, mobile clinic setups, and DRS partner sites.


Optain Resolve Tabletop Retina Camera (2024-2025)

Trials of the Optain Resolve Tabletop Retina Camera, initially stymied by device approval workflows, became a concrete reality as UPMC Enterprise, IT and CORAP collaborated with Optain stakeholders to develop a two-phase trial for implementation at the UPMC Vision Institute Urgent Eye Care Center (UECC) and Comprehensive Eye Service (CES) in Fall 2025.

Phase 1 wrapped in December 2025 at the UPMC Vision Institute. The usability and image quality of the retina camera were assessed by primary users in CES and UECC. Phase 2 is expected to launch in 2026 to assess Optain’s backend capabilities and network integrations in addition to the usability of the device in a primary care setting.


Topcon Maestro2 OCT Fundus Imaging Camera (2024)

CORAP set up the Maestro2 and its companion PC at mobile clinic events in 2025, trialing its usability in nontraditional clinic environments and remote integrations with EPIC and adjacent UPMC environments.